02
Jul

Vertex Pharmaceuticals won the FDA’s blessing to market a new combination therapy for cystic fibrosis, clearing the way for a drug key to the company’s future as it moves away from antiviral treatments.

…read more

Source: UPDATED: Vertex wins a crucial FDA nod for its cystic fibrosis combo, prices at $259,000

    

0 No comments